Pallas Capital Advisors LLC Dexcom Inc Transaction History

Pallas Capital Advisors LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$110.31 - $140.45 $4,963 - $6,320	45 Added 0.88%	5,179 $587,000
Q1 2024 Apr 15, 2024	BUY	$114.22 - $140.1 $9,480 - $11,628	83 Added 1.64%	5,134 $712,000
Q4 2023 Jan 22, 2024	SELL	$75.49 - $124.16 $1,887 - $3,104	-25 Reduced 0.49%	5,051 $626,000
Q3 2023 Nov 01, 2023	BUY	$86.06 - $137.93 $1,290 - $2,068	15 Added 0.3%	5,076 $473,000
Q2 2023 Jul 26, 2023	BUY	$112.47 - $130.98 $92,112 - $107,272	819 Added 19.31%	5,061 $650,000
Q1 2023 May 02, 2023	BUY	$104.0 - $122.92 $17,264 - $20,404	166 Added 4.07%	4,242 $492,000
Q4 2022 Jan 24, 2023	BUY	$84.98 - $122.67 $1,019 - $1,472	12 Added 0.3%	4,076 $0
Q3 2022 Nov 07, 2022	SELL	$76.35 - $94.18 $229 - $282	-3 Reduced 0.07%	4,064 $458,000
Q2 2022 Aug 11, 2022	BUY	$67.99 - $132.89 $192,887 - $377,008	2,837 Added 230.65%	4,067 $341,000
Q1 2022 Apr 20, 2022	SELL	$94.08 - $130.2 $28,976 - $40,101	-308 Reduced 20.03%	1,230 $605,000
Q4 2021 Feb 01, 2022	SELL	$129.87 - $162.82 $6,883 - $8,629	-53 Reduced 3.33%	1,538 $649,000
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $3,094 - $4,152	29 Added 1.86%	1,591 $986,000
Q2 2021 Aug 11, 2021	BUY	$80.99 - $107.93 $36,202 - $48,244	447 Added 40.09%	1,562 $804,000
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $94,540 - $116,785	1,115 New	1,115 $382,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Pallas Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pallas Capital Advisors LLC with notifications on news.